Retapamulin Completed Phase 3 Trials for Skin Infections, Bacterial Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00852540Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA